MedTrace Logo

Low-level Laser Therapy in Genitourinary Symptoms of Menopause

NCT06074120 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2026-03-18

No results posted yet for this study

Summary

The study will employ a prospective single-arm design involving menopausal women who present with genitourinary symptoms of menopause (GSM). Due to the preliminary nature of this study and the absence of a control group, the primary objective is to evaluate the feasibility and potential efficacy of low-level laser therapy in alleviating GSM in this population.

Conditions

  • Menopause Related Conditions

Interventions

DEVICE

Low-level laser therapy

Low-level laser therapy would be introduced via a vaginal probe (gain medium: Gallium-Aluminum-Arsenide, wavelength 660nm) for 30 minutes per treatment, once a week, for 8 courses.

Sponsors & Collaborators

  • National Taiwan University Hospital Beihu Branch

    collaborator OTHER

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Pei-chi Wu, MD. · National Taiwan University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-12
Primary Completion
2025-07-04
Completion
2026-02-26

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06074120 on ClinicalTrials.gov